Diagnostic Radiology and Nuclear Medicine (DRNM)
Diagnostic Radiology and Nuclear Medicine is an international peer reviewed open access scholarly journal aims to provide outstanding clinical care through expertise in medical imaging and interpretation for the early and best diagnostic output and effective treatment of diseases.
The journal’s scope encompasses complete array of diagnostic radiology [computerized tomography (CT), ultrasound (US), magnetic resonance imaging (MRI), plain films], interventional radiology [body, vascular, and neuro], nuclear medicine [positron emission tomography (PET), single-photon emission computed tomography (SPECT)] and combined modalities [PET/CT, SPECT/CT] over various disciplines such as Cardiology, Neurology, Endocrinology, Gastroenterology, Pulmonology, Orthopaedics and Nephrology.
The main emphasis is placed on the development of targeted imaging with radiopharmaceuticals within the broader context of molecular probes to enhance understanding and characterisation of the complex biological processes underlying disease and to develop, test and guide new treatment modalities, including radionuclide therapy.
Regular features include original research articles, rapid communication of preliminary data on innovative research, interesting case reports, editorials, and letters to the editor.
The journal targets nuclear medicine professionals, radiologists, specialists like radiopharmacists, surgeons, physicians and clinicians in a wide range of specialties, equipment and reagent manufacturers.
Copyright is retained by the authors and articles can be freely used and distributed by others. Articles are distributed under the terms of the Creative Commons Attribution License(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published by DRNM, is properly cited.